Skip to main content
2024 Annual Meeting Main banner
Final Program


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Lanyan (Lucy) Fang, PhD

Deputy Director, Quantitative Methods & Modeling, Research & Standards, Generic Drugs, Ctr for Drug Evaluation & Research
US Food & Drug Administration

Dr. Lanyan (Lucy) Fang is currently the Deputy Director, Div of Quantitative Methods & Modeling, Office of Research and Standards, OGD/CDER/FDA. Her current work is focused on applying quantitative clinical pharmacology approaches into regulatory review and facilitating better product lifecycle management. Dr. Fang has extensive pharmacometrics experience from both pharmaceutical industry and regulatory agency. Before her current position, she was a Senior Clinical Pharmacology Reviewer within the Office of Clinical Pharmacology, FDA and Senior Pharmacokinetist within Merck.

Disclosure information not submitted.

Presentation(s):

Email Lanyan (Lucy)